Immunotherapy for Cancer: Current Advances and Future Directions
International Journal of Molecular Sciences · 13.08.2026 · 27 (16) · 7216
DOI: 10.3390/ijms27167216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.08.2026. Verfasst von Tanya Saxena und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Child Health Development Research, Indian Council of Medical Research, New Delhi 110029, India. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunotherapy delivers a fundamental shift in the treatment of multiple cancers, offering hope for patients with cancer. Unlike conventional therapies, it leverages the patient’s immune system to precisely identify and destroy cancer cells. The remarkable journey of immunotherapy’s has revolutionized oncology and paved the way for the development of modern immunotherapies. Several approaches are applied for immunotherapy, including immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy and combination strategies. Various immunotherapies are being used for different types of cancers like skin, lung, bladder, kidney, liver, breast and blood cancers. Despite providing an effective cancer treatment, immunotherapies face some challenges in their clinical implementation. To overcome these limitations, future directions emphasize the development of personalized and combination therapies, the incorporation of AI and a good delivery system. The main aim of this review is to give an overview of the journey of evolution, different approaches, limitations, advances and future development for immunotherapy in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Child Health Development Research, Indian Council of Medical Research, New Delhi 110029, India.
- Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, India.
- Laboratory Oncology Unit, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, AIIMS, New Delhi 110029, India.
- Centre for Cancer Pathology, Indian Council of Medical Research, New Delhi 110029, India.
ORCID-Profile: Tanya Saxena, Himanshu Dhanda, Sandeep Kumar Swain, Sufian Zaheer, Pranay Tanwar, Fouzia Siraj, Bhavika Rishi, Aroonima Misra
Zitieren
APA
Saxena, T., Zaman, S., Dhanda, H., Swain, S. K., Kushwaha, N., Kaur, M., Kamal, R., Zaheer, S., Tanwar, P., Kumar, N., Siraj, F., Rishi, B., & Misra, A. (2026). Immunotherapy for Cancer: Current Advances and Future Directions. International Journal of Molecular Sciences, 27(16), 7216. https://doi.org/10.3390/ijms27167216
Vancouver
Saxena T, Zaman S, Dhanda H, Swain SK, Kushwaha N, Kaur M, et al. Immunotherapy for Cancer: Current Advances and Future Directions. International Journal of Molecular Sciences. 2026;27(16):7216. doi:10.3390/ijms27167216
BibTeX
@article{Saxena2026,
author = {Saxena, Tanya and Zaman, Shamsuz and Dhanda, Himanshu and Swain, Sandeep Kumar and Kushwaha, Neetu and Kaur, Manpreet and Kamal, Raj and Zaheer, Sufian and Tanwar, Pranay and Kumar, Neeraj and Siraj, Fouzia and Rishi, Bhavika and Misra, Aroonima},
title = {Immunotherapy for Cancer: Current Advances and Future Directions},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7216},
doi = {10.3390/ijms27167216}
}
EUVIMED